Discovery shows existing drugs can treat virus
A team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health has found existing drug compounds that can both stop Zika from replicating in the body and from damaging the crucial fetal brain cells that lead to birth defects in newborns.
One of the drugs is already on the market as a treatment for tapeworm.
“We focused on compounds that have the shortest path to clinical use,” said FSU Professor of Biological Science Hengli Tang. “This is a first step toward a therapeutic that can stop transmission of this disease.”
Tang, along with Johns Hopkins Professors Guo-Li Ming and Hongjun Song and National Institutes of Health scientist Wei Zheng identified two different groups of compounds that could potentially be used to treat Zika — one that stops the virus from replicating and the other that stops the virus from killing fetal brain cells, also called neuroprogenitor cells.
One of the identified compounds is the basis for a drug called Nicolsamide, a U.S. Food and Drug Administration approved drug that showed no danger to pregnant women in animal studies. It is commonly used to treat tapeworm.
This could be prescribed by a doctor today, though tests are still needed to determine a specific treatment regimen for the infection.
Their work is outlined in an article published Monday by Nature Medicine.
Though the Zika virus was discovered in 1947, there was little known about how it worked and its potential health implications — especially among pregnant women — until an outbreak occurred in South America last year. In the United States, there have been 529 cases of pregnant women contracting Zika, though most of those are travel related. As of Aug. 24, there have been 42 of locally transmitted cases in Florida.
The virus, among other diseases, can cause microcephaly in fetuses leading them to be born with severe birth defects.
“It’s so dramatic and irreversible,” Tang said. “The probability of Zika-induced microcephaly occurring doesn’t appear to be that high, but when it does, the damage is horrible.”
Researchers around the world have been feverishly working to better understand the disease — which can be transmitted both by mosquito bite and through a sexual partner — and also to develop medical treatments.
Tang, Ming and Song first met in graduate school 20 years ago and got in contact in January because Tang, a virologist, had access to the virus and Ming and Song, neurologists, had cortical stem cells that scientists needed to test.
The group worked at a breakneck pace with researchers from Ming and Song’s lab, traveling back and forth between Baltimore and Tang’s lab in Tallahassee where they had infected the cells with the virus.
In early March, the group was the first team to show that Zika indeed caused cellular phenotypes consistent with microcephaly, a severe birth defect where babies are born with a much smaller head and brain than normal.
They immediately delved into follow-up work and teamed with NIH’s Zheng, an expert on drug compounds, to find potential treatments for the disease.
Researchers screened 6,000 compounds that were either already approved by the FDA or were in the process of a clinical trial because they could be made more quickly available to people infected by Zika.
“It takes years if not decades to develop a new drug,” Song said. “In this sort of global health emergency, we don’t have time. So instead of using new drugs, we chose to screen existing drugs. In this way, we hope to create a therapy much more quickly.”
All of the researchers are continuing the work on the compounds and hope to begin testing the drugs on animals infected with Zika in the near future.
Learn more: FSU research team makes Zika drug breakthrough
The Latest on: Zika
via Google News
The Latest on: Zika
- How Meghan Markle, Prince Harry ‘Tricked’ The Public With Their Australia Tour on April 17, 2019 at 8:09 pm
The said move convinced many that Markle was not pregnant as the Pacific regions were infected with Zika virus which is not safe for pregnant women. “Obviously if you are a pregnant woman the advice ... […]
- Mosquitoes, Zika, Sexuality: Art Meets Science In A New Film Installation At PAMM on April 17, 2019 at 5:56 pm
In a dark gallery at the Perez Art Museum Miami, two screens on opposite sides of the room play a pair of films on an alternating loop—one follows scientists working in a lab to create genetically ... […]
- Zika Virus Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2024 on April 17, 2019 at 3:35 am
Apr 17, 2019 (Heraldkeeper via COMTEX) -- Market Study Report LLC adds Global Zika Virus market research providing newest industry data and covering future trends, allowing you to identify the ... […]
- Brazilian Researchers Develop Faster Test to Detect Zika Virus on April 15, 2019 at 6:38 am
BRASILIA, BRAZIL – A cheaper and faster test for detecting the Zika virus is being developed by Fiocruz (Oswaldo Cruz Foundation) in Pernambuco, Brazil. The researchers are hopeful that the new test ... […]
- What Ebola, HIV and Zika REALLY look like: Artist and scientist's fascinating watercolours on April 12, 2019 at 4:58 am
An artist shows feared viruses such as Ebola in a completely new light, by painting them in incredible detail. Professor David Goodsell also happens to be a structural biologist at Scripps Research in ... […]
- Exscalate Platform Addresses Zika Epidemic on April 11, 2019 at 9:32 pm
April 11 — Powered by CINECA’s Marconi supercomputer, EXSCALATE (EXaSCale smArt pLatform Against paThogEns) is accelerating the search for new drugs, setting a new record: a “chemical library” of 500 ... […]
- Zika Virus Update for Summer 2019 on April 10, 2019 at 11:21 am
With summer just around the corner is St. Louis, many people are planning their BBQs, picnics, and relaxing days enjoying the sunshine. But as the weather warms up, pests will begin to emerge from ... […]
- Chembio's zika, dengue and chikungunya multiplex test approved in Brazil on April 9, 2019 at 10:41 am
Agência Nacional de Vigilância Sanitária ((ANVISA)), Brazil’s health regulatory agency approves Chembio Diagnostics' (NASDAQ:CEMI) DPP Zika/Dengue/Chikungunya System. Chembio’s DPP Zika ... […]
- Molecules with strong anti-Zika potential created by researchers on April 8, 2019 at 4:07 am
A new study published in the Journal of Medicinal Chemistry details a promising method for treating the Zika virus. Transmitted by the Aedes mosquito, the Zika virus has become a worldwide health ... […]
- Synthetic antibody rapidly protects mice and monkeys from Zika on April 5, 2019 at 2:31 pm
A DNA-encoded monoclonal antibody prevents Zika infection in mice and non-human primates, researchers report April 5th in the journal Molecular Therapy. Injections of synthetic DNA encoding the ... […]
via Bing News